-
1
-
-
0028790440
-
Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma
-
Philip T, Guglielmi C, Hagenbeek A, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med. 1995;333:1540-1545.
-
(1995)
N Engl J Med.
, vol.333
, pp. 1540-1545
-
-
Philip, T.1
Guglielmi, C.2
Hagenbeek, A.3
-
2
-
-
8944220233
-
A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma
-
Attal M, Harousseau JL, Stoppa AM, et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med. 1996;335:91-97.
-
(1996)
N Engl J Med.
, vol.335
, pp. 91-97
-
-
Attal, M.1
Harousseau, J.L.2
Stoppa, A.M.3
-
3
-
-
2942712161
-
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
-
Collins RH, Shpilberg O, Drobyski WR, et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol. 1997;15:433-444.
-
(1997)
J Clin Oncol.
, vol.15
, pp. 433-444
-
-
Collins, R.H.1
Shpilberg, O.2
Drobyski, W.R.3
-
4
-
-
0027509704
-
Donor leukocyte infusions after chemotherapy for patients relapsing with acute leukemia following allogeneic BMT
-
Szer J, Grigg AP, Phillips GL, Sheridan WP. Donor leukocyte infusions after chemotherapy for patients relapsing with acute leukemia following allogeneic BMT. Bone Marrow Transplant. 1993;11:109-111.
-
(1993)
Bone Marrow Transplant.
, vol.11
, pp. 109-111
-
-
Szer, J.1
Grigg, A.P.2
Phillips, G.L.3
Sheridan, W.P.4
-
5
-
-
0032992942
-
Reinventing bone marrow transplantation: Reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancy
-
Champlin R, Khouri I, Kornblau S, et al. Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancy. Current Opinion Oncol. 1999;11:87-95.
-
(1999)
Current Opinion Oncol.
, vol.11
, pp. 87-95
-
-
Champlin, R.1
Khouri, I.2
Kornblau, S.3
-
6
-
-
0031879197
-
Transplant-lite: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies
-
Khouri IF, Keating M, Körbling M, et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol. 1998;16:2817-2824.
-
(1998)
J Clin Oncol.
, vol.16
, pp. 2817-2824
-
-
Khouri, I.F.1
Keating, M.2
Körbling, M.3
-
7
-
-
0022349817
-
Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer
-
Rosenberg SA, Lotze MT, Muul LM, et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med. 1985;313:1485-1492.
-
(1985)
N Engl J Med.
, vol.313
, pp. 1485-1492
-
-
Rosenberg, S.A.1
Lotze, M.T.2
Muul, L.M.3
-
8
-
-
0023115642
-
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone
-
Rosenberg SA, Lotze MT, Muul LM, et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med. 1987;316:889-897.
-
(1987)
N Engl J Med.
, vol.316
, pp. 889-897
-
-
Rosenberg, S.A.1
Lotze, M.T.2
Muul, L.M.3
-
9
-
-
0027529476
-
Prospective randomized trial of high-dose interleukin-2 alone or in conjugation with lymphokine-activated killer cells for the treatment of patients with advanced cancer
-
Rosenberg SA, Lotze MT, Yang JC, et al. Prospective randomized trial of high-dose interleukin-2 alone or in conjugation with lymphokine-activated killer cells for the treatment of patients with advanced cancer. J Natl Cancer Inst. 1993;85:622-632.
-
(1993)
J Natl Cancer Inst.
, vol.85
, pp. 622-632
-
-
Rosenberg, S.A.1
Lotze, M.T.2
Yang, J.C.3
-
10
-
-
0025824067
-
+ cells: Examination of morphology, functions, T-cell receptor rearrangement, and poreforming protein expression
-
+ cells: examination of morphology, functions, T-cell receptor rearrangement, and poreforming protein expression. Cell Immunol. 1991;136:486-495.
-
(1991)
Cell Immunol.
, vol.136
, pp. 486-495
-
-
Ortaldo, J.R.1
Winkler-Pickett, R.T.2
Yagita, H.3
Young, H.A.4
-
11
-
-
0022535970
-
A subset of natural killer cells in peripheral blood displays a mature T cell phenotype
-
Schmidt RE, Murray C, Daley JF, et al. A subset of natural killer cells in peripheral blood displays a mature T cell phenotype. J Exp Med. 1986;164:351-356.
-
(1986)
J Exp Med.
, vol.164
, pp. 351-356
-
-
Schmidt, R.E.1
Murray, C.2
Daley, J.F.3
-
12
-
-
0022589079
-
The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes
-
Lanier LL, Le AM, Civin CI, et al. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol. 1986;136:4480-4486.
-
(1986)
J Immunol.
, vol.136
, pp. 4480-4486
-
-
Lanier, L.L.1
Le, A.M.2
Civin, C.I.3
-
13
-
-
0028103808
-
+ cells derived from T-cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency
-
+ cells derived from T-cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. J Immunol. 1994;153:1687-1696.
-
(1994)
J Immunol.
, vol.153
, pp. 1687-1696
-
-
Lu, P.H.1
Negrin, R.S.2
-
14
-
-
0025856106
-
Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity
-
Schmidt-Wolf IGH, Negrin RS, Kiem HP, et al. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity. J Exp Med. 1991;174:139-149.
-
(1991)
J Exp Med.
, vol.174
, pp. 139-149
-
-
Schmidt-Wolf, I.G.H.1
Negrin, R.S.2
Kiem, H.P.3
-
16
-
-
0028917966
-
Potential of autologous immunologic effector cells for bone marrow purging in patients with chronic myeloid leukemia
-
Scheffold C, Brandt K, Johnston V, et al. Potential of autologous immunologic effector cells for bone marrow purging in patients with chronic myeloid leukemia. Bone Marrow Transplant. 1995; 15:33-39.
-
(1995)
Bone Marrow Transplant.
, vol.15
, pp. 33-39
-
-
Scheffold, C.1
Brandt, K.2
Johnston, V.3
-
17
-
-
0032211175
-
+ cytotoxic cells from chronic myeloid leukemia patients: In vitro and in vivo efficacy in severe combined immunodeficiency disease mice
-
+ cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice. Blood. 1998;92:3318-3327.
-
(1998)
Blood
, vol.92
, pp. 3318-3327
-
-
Hoyle, C.1
Bangs, C.D.2
Pearl, C.3
-
18
-
-
0032693955
-
Visualizing the kinetics of tumor-cell clearance in living animals
-
Sweeney TJ, Mailänder V, Tucker AA, et al. Visualizing the kinetics of tumor-cell clearance in living animals. Proc Natl Acad Sci U S A. 1999;96:12044-12049.
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, pp. 12044-12049
-
-
Sweeney, T.J.1
Mailänder, V.2
Tucker, A.A.3
-
19
-
-
0031205120
-
Cellular immunotherapy following autologous hematopoietic progenitor cell transplantation
-
Lu PH, Negrin RS. Cellular immunotherapy following autologous hematopoietic progenitor cell transplantation. Biol Blood Marrow Transplant. 1997;3:113-121.
-
(1997)
Biol Blood Marrow Transplant.
, vol.3
, pp. 113-121
-
-
Lu, P.H.1
Negrin, R.S.2
-
20
-
-
0032170052
-
Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation
-
Guillaume T, Rubinstein DB, Symann M. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood. 1998;92:1471-1490.
-
(1998)
Blood
, vol.92
, pp. 1471-1490
-
-
Guillaume, T.1
Rubinstein, D.B.2
Symann, M.3
-
21
-
-
0028089348
-
Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation
-
Neubauer MA, Benyunes MC, Thompson JA, et al. Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 1994;13:311-316.
-
(1994)
Bone Marrow Transplant.
, vol.13
, pp. 311-316
-
-
Neubauer, M.A.1
Benyunes, M.C.2
Thompson, J.A.3
-
22
-
-
0026657518
-
Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors
-
Bosly A, Guillaume T, Brice P, et al. Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors. Exp Hematol. 1992;20:962-968.
-
(1992)
Exp Hematol.
, vol.20
, pp. 962-968
-
-
Bosly, A.1
Guillaume, T.2
Brice, P.3
-
23
-
-
0029099188
-
Immunotherapy with interleukin-2 with or without lymphokine-activated killer cells after autologous bone marrow transplantation for malignant lymphoma: A feasibility trial
-
Benyunes MC, Higuchi C, York A, et al. Immunotherapy with interleukin-2 with or without lymphokine-activated killer cells after autologous bone marrow transplantation for malignant lymphoma: a feasibility trial. Bone Marrow Transplant. 1995;16:283-288.
-
(1995)
Bone Marrow Transplant.
, vol.16
, pp. 283-288
-
-
Benyunes, M.C.1
Higuchi, C.2
York, A.3
-
24
-
-
0028301366
-
Propagation of large numbers of T cells with natural killer cell markers
-
Schmidt-Wolf IGH, Lefterova P, Johnston, et al. Propagation of large numbers of T cells with natural killer cell markers. Br J Haematol. 1994;87:453-458.
-
(1994)
Br J Haematol.
, vol.87
, pp. 453-458
-
-
Schmidt-Wolf, I.G.H.1
Lefterova, P.2
Johnston3
-
25
-
-
0028340717
-
G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: Safety, kinetics of mobilization, and composition of the graft
-
Dreger P, Haferlach T, Eckstein V, et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol. 1994;87:609-613.
-
(1994)
Br J Haematol.
, vol.87
, pp. 609-613
-
-
Dreger, P.1
Haferlach, T.2
Eckstein, V.3
-
26
-
-
0028843985
-
Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease
-
Pan L, Delmonte J, Jalonen CK, Ferrara JLM. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood. 1995;86:4422-4429.
-
(1995)
Blood
, vol.86
, pp. 4422-4429
-
-
Pan, L.1
Delmonte, J.2
Jalonen, C.K.3
Ferrara, J.L.M.4
-
27
-
-
0032717657
-
Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions
-
Hartung T, Doecke WD, Bundschuh D, et al. Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions. Clin Pharmacol Ther. 1999;66:415-424.
-
(1999)
Clin Pharmacol Ther.
, vol.66
, pp. 415-424
-
-
Hartung, T.1
Doecke, W.D.2
Bundschuh, D.3
-
28
-
-
0032864809
-
Recombinant human granulocyte colony-stimulating factor (rHuG-CSF): Effects on lymphocyte phenotype and function
-
Rutella S, Rumi C, Sica S, Leone G. Recombinant human granulocyte colony-stimulating factor (rHuG-CSF): effects on lymphocyte phenotype and function. J Interferon Cytokine Res. 1999;19: 989-994.
-
(1999)
J Interferon Cytokine Res.
, vol.19
, pp. 989-994
-
-
Rutella, S.1
Rumi, C.2
Sica, S.3
Leone, G.4
-
29
-
-
0032921767
-
Granulocyte colony-stimulating factor (G-CSF) transiently suppresses mitogen-stimulated T-cell proliferative response
-
Reyes E, Garcia-Castro I, Esquivel F, et al. Granulocyte colony-stimulating factor (G-CSF) transiently suppresses mitogen-stimulated T-cell proliferative response. Br J Cancer. 1999;80:229-235.
-
(1999)
Br J Cancer
, vol.80
, pp. 229-235
-
-
Reyes, E.1
Garcia-Castro, I.2
Esquivel, F.3
-
30
-
-
0003284325
-
Autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin's disease and non-Hodgkin's lymphoma
-
Leemhuis T, Wells S, Scheffold C, et al. Autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin's disease and non-Hodgkin's lymphoma [abstract 3624]. Blood. 2000;96(suppl 1a):839a.
-
(2000)
Blood
, vol.96
, Issue.SUPPL. 1A
-
-
Leemhuis, T.1
Wells, S.2
Scheffold, C.3
-
31
-
-
85112358540
-
Generation of cytokine-induced killer cells (CIK) from leukemic samples and its in vitro cytotoxicity against autologous leukemia
-
Linn YC, Lau LC, Hui KM. Generation of cytokine-induced killer cells (CIK) from leukemic samples and its in vitro cytotoxicity against autologous leukemia [abstract 3841]. Blood. 2000; 96(suppl 1b):41b.
-
(2000)
Blood
, vol.96
, Issue.SUPPL. 1B
-
-
Linn, Y.C.1
Lau, L.C.2
Hui, K.M.3
|